Menu
  • Join us
  • Login
 

Search for abstracts

You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.


EFFECTIVENESS AND SAFETY OF OCRELIZUMAB IN RELAPSING-REMITTING AND PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

  • At: Virtual 2020 (2020)
  • Type: Poster
  • Poster code: POS-HPS-011
  • By: CANO DOMíNGUEZ, Sergio (Hospital Universitario Virgen de las Nieves, Hospital pharmacy, Spain)
  • Co-author(s): María Del Mar Sánchez Suárez: Hospital pharmacy, Hospital Universitario Virgen de las Nieves, Granada, Spain
    Sergio Cano Domínguez: Hospital pharmacy, Hospital Universitario Virgen de las Nieves, Granada, Spain
    Eduardo Tejedor Tejada: Hospital pharmacy, Hospital Universitario Torrecárdenas, Almería, Spain
  • Abstract:

    Background

    Ocrelizumab is a recombinant humanized monoclonal antibody that acts selectively against B cells expressing CD20.

    Purpose

    Assess effectiveness and safety of ocrelizumab in patients with relapsing-remitting (RRMS) and primary progressive multiple sclerosis (PPMS).

    Methods

    Retrospective observational multicenter study of patients

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 23 September 2026

FIP Congresses